CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the ... - Business Wire (press release)

CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the ...Business Wire (press release)TEVA ANNOUNCES PUBLICATION OF PHASE III TRIAL DATA OF FREMANEZUMAB FOR THE PREVENTIVE TREATMENT OF EPISODIC MIGRAINE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Teva Pharmaceutical Industries Ltd.